The Centers for Medicare & Medicaid Services (“CMS”) published an Interim Final Rule on November 27, 2020 that creates a new drug reimbursement model tying Medicare Part B drug reimbursement for certain drugs to price limits in place in other countries (“Most Favored Nation Model” or “MFN Model”). Scheduled to begin January 1, 2021,... READ MORE
New CMS Most Favored Nation Drug Pricing Rule Could Negatively Impact the Bottom Lines of Hospitals, Physician Practices
Posted on December 4, 2020 in Health Law News
Published by: Hall Render